UK Health Check-up Market (2024 - 2030) Size, Share & Trends Analysis Report By Test Type (Blood, Urine, Body Fluid Tests, Imaging-based Tests), By End-use (Enterprise, Individual), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Test Type
                       1.2.2. End-use
                       1.2.3. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Test Type and End-use outlook
                   2.3. Competitive Insights
Chapter 3. UK Health Check-up Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Increasing prevalence of diseases
                           3.2.1.2. Growing investments in population screening
                           3.2.1.3. Growing geriatric population
                           3.2.1.4. Adoption of digital technology
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. High cost associated with screening
                           3.2.2.2. Psychological Factors And Knowledge, Attitudes, & Beliefs
                       3.2.3. Market challenge analysis
                           3.2.3.1. Lack of awareness
                       3.2.4. Market Opportunity Analysis
                           3.2.4.1. Rising medical tourism
                   3.3. UK Health Check-up Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s Five Forces
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. UK Health Check-up Market: Test Type Estimates & Trend Analysis
                   4.1. UK Health Check-up Market: Test Type Dashboard
                   4.2. UK Health Check-up Market: Test Type Movement Analysis
                   4.3. UK Health Check-up Market by Test Type, Revenue
                   4.4. Blood, Urine, Body Fluid Tests
                       4.4.1. Blood, urine, body fluid tests market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. Imaging-based tests (Xray, CT, US, MRI)
                       4.5.1. Imaging based tests (Xray, CT, US, MRI) market estimates and forecasts 2018 to 2030 (USD Million)
                   4.6. Non-imaging Tests (ECG, CPET, NCS, EMG, EEG)
                       4.6.1. Non-imaging tests (ECG, CPET, NCS, EMG, EEG) market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. UK Health Check-up Market: End-use Estimates & Trend Analysis
                   5.1. UK Health Check-up Market: End-use Dashboard
                   5.2. UK Health Check-up Market: End-use Movement Analysis
                   5.3. UK Health Check-up Market by End-use, Revenue
                   5.4. Enterprise
                       5.4.1. Enterprise market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.2. Private (Corporate) Sector
                           5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.3. Government Sector
                           5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.4. Insurance
                           5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Individual
                       5.5.1. Individual market estimates and forecasts 2018 to 2030 (USD Million)
                       5.5.2. Out of Pocket- Direct Payment for Health Check
                           5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.5.3. Individual Health Insurance Plan
                           5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                   6.1. Recent Developments & Impact Analysis, By Key Market Participants
                   6.2. Company/Competition Categorization
                   6.3. Vendor Landscape
                       6.3.1. List of key distributors and channel partners
                       6.3.2. Key customers
                       6.3.3. Key company market share analysis, 2023
                       6.3.4. Quest Diagnostics Incorporated
                           6.3.4.1. Company overview
                           6.3.4.2. Financial performance
                           6.3.4.3. Product benchmarking
                           6.3.4.4. Strategic initiatives
                       6.3.5. Laboratory Corporation of America Holdings
                           6.3.5.1. Company overview
                           6.3.5.2. Financial performance
                           6.3.5.3. Product benchmarking
                           6.3.5.4. Strategic initiatives
                       6.3.6. SYNLAB International GmbH
                           6.3.6.1. Company overview
                           6.3.6.2. Financial performance
                           6.3.6.3. Product benchmarking
                           6.3.6.4. Strategic initiatives
                       6.3.7. OPKO Health, Inc.
                           6.3.7.1. Company overview
                           6.3.7.2. Financial performance
                           6.3.7.3. Product benchmarking
                           6.3.7.4. Strategic initiatives
                       6.3.8. Eurofins Scientific
                           6.3.8.1. Company overview
                           6.3.8.2. Financial performance
                           6.3.8.3. Product benchmarking
                           6.3.8.4. Strategic initiatives
                       6.3.9. UNILABS
                           6.3.9.1. Company overview
                           6.3.9.2. Financial performance
                           6.3.9.3. Product benchmarking
                           6.3.9.4. Strategic initiatives
                       6.3.10. Sonic Healthcare Limited
                           6.3.10.1. Company overview
                           6.3.10.2. Financial performance
                           6.3.10.3. Product benchmarking
                           6.3.10.4. Strategic initiatives
                       6.3.11. ARUP Laboratories
                           6.3.11.1. Company overview
                           6.3.11.2. Financial performance
                           6.3.11.3. Product benchmarking
                           6.3.11.4. Strategic initiatives
                       6.3.12. Q2 Solutions
                           6.3.12.1. Company overview
                           6.3.12.2. Financial performance
                           6.3.12.3. Product benchmarking
                           6.3.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 UK health check-up market, by test type, 2018 - 2030 (USD Million)
Table 3 UK health check-up market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 UK health check-up market: market outlook
Fig. 14 Drug screening competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 UK health check-up market driver impact
Fig. 18 UK health check-up market restraint impact
Fig. 19 UK health check-up market: Test type movement analysis
Fig. 20 UK health check-up market: Test type outlook and key takeaways
Fig. 21 Blood, urine, body fluids tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Imaging-based tests (Xray, CT, US, MRI) estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Non-imaging tests (ECG, CPET, NCS, EMG, EEG) estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 UK health check-up market: End-use movement analysis
Fig. 25 UK health check-up market: End-use outlook and key takeaways
Fig. 26 Enterprise market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Individual estimates and forecast, 2018 - 2030 (USD Million)